1. 首页
  2. 细胞
  3. 正文

Lesinurad_878672-00-5_Absin

产品信息
抗原名称
URAT1
商品描述

Lesinurad is a selective <b>uric acid reabsorption</b> inhibitor (SURI) under investigation for treatment of gout in combination with xanthine oxidase inhibitors.

分子量
404.28
纯度

>98%

可溶性
体外:
DMSO 80mg/mL(197.88mM)
Ethanol 54mg/mL(133.57mM)
Water <1mg/mL

In vitro(体外研究)
Lesinurad inhibits the uric acid transport activity of human URAT1 (hURAT1) at a 20-fold higher potency compared to rat URAT1 (rURAT1), with IC50's of 3.36 and 74.84 μM, respectively. Lesinurad inhibits hURAT1 through an interaction that involves a critical residue, Phe365.
In vivo(体内研究)
Lesinurad (RDEA594) shows better pharmacokinetics than its pro-drug RDEA806. The 100 mg dose of Lesinurad exhibits a phamacological effect in the range of that produced by 300 mg to 800 mg single doses of RDEA806.
背景
分子式
C17H14BrN3O2S
CAS号
878672-00-5
制备和贮存
保存方式
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.

参考图片

文档下载: W 导出为Lesinurad_878672-00-5_Absin.doc文档

本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/article/24781.html

(function(){ var src = (document.location.protocol == "http:") ? "http://js.passport.qihucdn.com/11.0.1.js?1d7dde81dc0903e04d3ac0b9599444f6":"https://jspassport.ssl.qhimg.com/11.0.1.js?1d7dde81dc0903e04d3ac0b9599444f6"; document.write('<\/mip-script>'); })(); (function(){ var bp = document.createElement('script'); var curProtocol = window.location.protocol.split(':')[0]; if (curProtocol === 'https') { bp.src = 'https://zz.bdstatic.com/linksubmit/push.js'; } else { bp.src = 'http://push.zhanzhang.baidu.com/push.js'; } var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(bp, s); })();